Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
Joensuu H, Fraser J, Wildiers H, Huovinen R, Auvinen P, Utriainen M, Villman KK, Halonen P, Granstam-Björneklett H, Tanner M, Sailas L, Turpeenniemi-Hujanen T, Yachnin J, Huttunen T, Neven P, Canney P, Harvey VJ, Kellokumpu-Lehtinen PL, Lindman H. Joensuu H, et al. Among authors: turpeenniemi hujanen t. JAMA Netw Open. 2024 Aug 1;7(8):e2429772. doi: 10.1001/jamanetworkopen.2024.29772. JAMA Netw Open. 2024. PMID: 39186271 Free article. Clinical Trial.
Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.
Ollikainen RK, Sippola A, Turpeenniemi-Hujanen T, Kuitunen H, Porvari K, Haapasaari KM, Kuusisto MEL, Klaavuniemi T, Kuittinen O. Ollikainen RK, et al. Among authors: turpeenniemi hujanen t. Anticancer Res. 2024 Aug;44(8):3255-3259. doi: 10.21873/anticanres.17143. Anticancer Res. 2024. PMID: 39060054
Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice.
Rajamaki A, Sorigue M, Prusila REI, Kuusisto MEL, Kuitunen H, Jantunen E, Mercadal S, Turpeenniemi-Hujanen T, Sancho JM, Sunela K, Kuittinen O. Rajamaki A, et al. Among authors: turpeenniemi hujanen t. Acta Oncol. 2024 May 6;63:267-272. doi: 10.2340/1651-226X.2024.24377. Acta Oncol. 2024. PMID: 38709114 Free PMC article.
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors.
Kaprio E, Prusila R, Tokola S, Kuusisto MEL, Jantunen E, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O. Kaprio E, et al. Among authors: turpeenniemi hujanen t. Cancer Med. 2024 Jan;13(1):e6898. doi: 10.1002/cam4.6898. Epub 2024 Jan 1. Cancer Med. 2024. PMID: 38164067 Free PMC article.
Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation.
Chan MC, Savela J, Ollikainen RK, Teppo HR, Miinalainen I, Pirinen R, Kari EJM, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O, Kuusisto MEL. Chan MC, et al. Among authors: turpeenniemi hujanen t. Oxid Med Cell Longev. 2021 Feb 1;2021:8026941. doi: 10.1155/2021/8026941. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33603952 Free PMC article.
161 results